Literature DB >> 8364907

Multiple breakpoints within the BCL-1 locus in B-cell lymphoma: rearrangements of the cyclin D1 gene.

C J de Boer1, S Loyson, P M Kluin, H C Kluin-Nelemans, E Schuuring, J H van Krieken.   

Abstract

Centrocytic lymphoma (CC) and intermediately differentiated lymphocytic lymphoma (IDL) are B-cell non-Hodgkin's lymphomas composed of lymphocytes presumably derived from follicle mantle cells. In these lymphomas, a specific chromosomal translocation, t(11;14)(q13;q32), has been described. Previous studies suggested an association between t(11;14) chromosomal translocations and BCL-1 rearrangements. To evaluate the association between BCL-1 rearrangements and CC/IDL, Southern blot analysis was performed on a panel of 20 cases of CC/IDL, 22 cases of morphologically similar non-Hodgkin's lymphomas, 11 cases of chronic B-cell leukemias, and 2 cases of myelomas. We used various probes covering a considerable proportion of the 120-kilobase BCL-1 locus, and rearrangements in 50% of CC/IDL (10 of 20) were detected. In CC, all 4 breakpoints were located at the major translocation cluster (MTC). In contrast, in IDL, rearrangements were detected in 3 different cluster regions: 2 cases in the MTC, 2 cases with a breakpoint 24 kilobases outside the MTC, and 2 additional cases with breakpoints found 3 kilobases 5' of the first exon of the PRAD1/CCND1 gene, which is located 120 kilobases outside the MTC. In addition, one leukemia showed a breakpoint 63 kilobases outside the MTC. In all cases, there was comigration of the rearranged 11q13 fragment and the immunoglobulin heavy chain-joining gene complex, indicating a t(11;14)(q13;q32) chromosomal rearrangement. Our results show that Southern blot analysis is helpful to identify CC/IDL, but multiple breakpoints are present over a large region, and therefore, many probes are necessary to cover all breakpoints.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8364907

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  18 in total

1.  Detection of translocation t(11;14)(q13;q32) in mantle cell lymphoma by fluorescence in situ hybridization.

Authors:  J Y Li; F Gaillard; A Moreau; J L Harousseau; C Laboisse; N Milpied; R Bataille; H Avet-Loiseau
Journal:  Am J Pathol       Date:  1999-05       Impact factor: 4.307

2.  Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3.

Authors:  M Chesi; E Nardini; L A Brents; E Schröck; T Ried; W M Kuehl; P L Bergsagel
Journal:  Nat Genet       Date:  1997-07       Impact factor: 38.330

Review 3.  Molecular pathology of low grade malignant lymphomas.

Authors:  H Ratech
Journal:  Med Oncol       Date:  1995-09       Impact factor: 3.064

4.  Determination of cyclin D1 and CD20 mRNA levels by real-time quantitative RT-PCR from archival tissue sections of mantle cell lymphoma and other non-Hodgkin's lymphomas.

Authors:  Vilmos A Thomázy; Rajyalakshmi Luthra; Margaret O Uthman; Peter J A Davies; L Jeffrey Medeiros
Journal:  J Mol Diagn       Date:  2002-11       Impact factor: 5.568

5.  Expression of cyclin D1 in epithelial tissues of transgenic mice results in epidermal hyperproliferation and severe thymic hyperplasia.

Authors:  A I Robles; F Larcher; R B Whalin; R Murillas; E Richie; I B Gimenez-Conti; J L Jorcano; C J Conti
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

Review 6.  Genomic profiles in B cell lymphoma.

Authors:  Masao Seto
Journal:  Int J Hematol       Date:  2010-08-27       Impact factor: 2.490

7.  BCL-6 and other genomic alterations in non-Hodgkin's lymphoma (NHL).

Authors:  M Butler; N Corbally; P A Dervan; D N Carney
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

8.  Luteolin inhibits cell proliferation during Azoxymethane-induced experimental colon carcinogenesis via Wnt/ β-catenin pathway.

Authors:  Pandurangan Ashokkumar; Ganapasam Sudhandiran
Journal:  Invest New Drugs       Date:  2009-12-15       Impact factor: 3.850

9.  IgH partner breakpoint sequences provide evidence that AID initiates t(11;14) and t(8;14) chromosomal breaks in mantle cell and Burkitt lymphomas.

Authors:  Harvey A Greisman; Zhengfei Lu; Albert G Tsai; Timothy C Greiner; Hye Son Yi; Michael R Lieber
Journal:  Blood       Date:  2012-08-20       Impact factor: 22.113

10.  Cyclin D1 overexpression vs. retinoblastoma inactivation: implications for growth control evasion in non-small cell and small cell lung cancer.

Authors:  I E Schauer; S Siriwardana; T A Langan; R A Sclafani
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.